Hubei Haosun Pharmaceutical Co., Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- China
- Registered address
- No.20 Juxian Road, Gedian Economic & Technology Development Area, Ezhou, Hubei 436070, China (CHN)
- Operations here
- api manufacture
- FDA identifiers
- FEI 3005178749 · DUNS 527128525
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2025-08-01
- NAIDrug Quality Assurance2018-03-09
- VAIDrug Quality Assurance2016-09-02
- VAIDrug Quality Assurance2013-11-15
- VAIDrug Quality Assurance2011-07-16
Drugs this plant is listed as making
1 distinct drugs across 1 products name this site in their FDA label.
- Irinotecan HydrochlorideIpsen Biopharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.